TREM2 plays a critical neuroprotective during early and mid-term Alzheimer's disease (AD), as it suppresses the Aβ diffusion and accumulation by regulating microglial activation around amyloid plaques3,19,20. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.